The Corporation for Supportive Housing (CSH) Metro Team is participating in a five-year, $3.85 million grant from the National Institute on Drug Abuse (NIDA) for a project titled “Implementation of Overdose Prevention Practices in Permanent Supportive Housing,” in partnership with Principal Investigator Kelly M. Doran, M.D. at NYU School of Medicine and other investigators from NYU.
The study will examine the implementation of evidence-based practices to prevent drug overdose for tenants in permanent supportive housing (PSH) in New York City and New York’s Capital Region.
It will also include a robust stakeholder engagement process with PSH tenants. The study builds on prior work that CSH led to identifying overdose risks in PSH.